Robert Cady, MD
Glaucoma Specialist · Portland, MENPI 1174529564
Payments from drug & device makers
Across 151 payments — averaging $107.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$12K
- US Retina LLC$2K
- AbbVie$874
- Alcon$760
- NEW World Medical,inc.$146
- Bausch & Lomb Americas Inc.$136
- plus $427 from 7 others
What the payments were for
- Food & beverage$4,15672%
- Gifts$451%
- Ownership interest$1,56027%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 37 | $12,293 |
| US Retina LLC | 12 | $1,560 |
| AbbVie(2 entities) | 59 | $874 |
| Alcon | 17 | $760 |
| NEW World Medical,inc. | 1 | $146 |
| Bausch & Lomb Americas Inc. | 6 | $136 |
| Aerie Pharmaceuticals, Inc. | 5 | $121 |
| Sight Sciences, Inc. | 7 | $89 |
| Tarsus Pharmaceuticals, Inc. | 2 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| Novartis | 1 | $42 |
| Genentech USA, Inc. | 1 | $22 |
| Thea Pharma Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iStent inject W$468
- KXL System$349
- Photrexa$349
- AcrySof IQ VIVITY$234
- IACCESS$211
- Kahook Dual Blade$146
- Clearpath$146
- Ahmed Glaucoma Valve$146
- Streamline$146
- Via360$146
- iS3-iStent infiniteTrabecular Micro-Bypass System Model iS3$142
- iStent infinite Trabecular Micro-Bypass System Model iS3$142
- iAccess Precision Blade$142
- iPRIME Viscodelivery System$142
- ARGOS$142
- iDose$126
- iStent inject Trabecular Micro-Bypass Stent System$111
- LenSx$104
How this compares
Too few glaucoma specialist providers in Maineto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 420 | $274,458 |
| CombiganBrimonidine Tartrate/Timolol | 134 | $50,290 |
| Brimonidine Tartrate | 122 | $21,480 |
| Travoprost | 123 | $16,285 |
| Timolol Maleate | 460 | $13,889 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 74 | $12,910 |
| Brinzolamide | 64 | $11,757 |
| Difluprednate | 129 | $11,732 |
| RhopressaNetarsudil Mesylate | 21 | $11,120 |
| Latanoprost | 756 | $9,613 |
| Alphagan PBrimonidine Tartrate | 21 | $9,553 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 371 | $7,764 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 17 | $5,770 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 36 | $5,627 |
| Methazolamide | 21 | $5,287 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Alphagan P | $874 | $334,301575 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa | $121 | $11,12021 claims |
| AlconSimbrinza | $760 | $5,77017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few glaucoma specialist providers in Maineon file to place this against a meaningful peer group, so we don't.
Other glaucoma specialist in Portland
- Curtis LibbyPortland$5K
- George ShafranovBangor$391
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.